These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

117 related items for PubMed ID: 10392356

  • 21. Evidence of a circulating growth hormone stimulating factor other than growth hormone releasing hormone in a patient with pituitary tumour and acromegaly.
    Hulting AL, Wersäll J, Werner S.
    Acta Endocrinol (Copenh); 1985 Jul; 109(3):289-94. PubMed ID: 3927648
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Diagnosis, treatment, and outcome of pituitary tumors and other abnormal intrasellar masses. Retrospective analysis of 353 patients.
    Gsponer J, De Tribolet N, Déruaz JP, Janzer R, Uské A, Mirimanoff RO, Reymond MJ, Rey F, Temler E, Gaillard RC, Gomez F.
    Medicine (Baltimore); 1999 Jul; 78(4):236-69. PubMed ID: 10424206
    [Abstract] [Full Text] [Related]

  • 25. Circulating growth hormone isoforms in girls with Turner's syndrome.
    Blethen SL, Albertsson-Wikland K, Faklis EJ, Chasalow FI.
    J Clin Endocrinol Metab; 1994 Jun; 78(6):1439-43. PubMed ID: 8200948
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Pathological and experimental investigations in a case of gigantism.
    Fazekas I, Pásztor E, Slowik F, Bálint K, Dobronyi I, Bácsy E, Gyévai A, Péter F, Blatniczky L, Varga I.
    Acta Neuropathol; 1993 Jun; 85(2):167-74. PubMed ID: 8382895
    [Abstract] [Full Text] [Related]

  • 28. Plasma transport of the 20,000-dalton variant of human growth hormone (20K): evidence for a 20K-specific binding site.
    Baumann G, Shaw MA.
    J Clin Endocrinol Metab; 1990 Nov; 71(5):1339-43. PubMed ID: 2172278
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Cellular internalization and trafficking of 20 KDa human growth hormone.
    Hai-Nan L, Hui-Lin L, Zi-Qi Z, Gan L, Xue-Qi F, Xin Z.
    Gen Comp Endocrinol; 2019 Jan 01; 270():82-89. PubMed ID: 30339804
    [Abstract] [Full Text] [Related]

  • 31. Congenital gigantism due to growth hormone-releasing hormone excess and pituitary hyperplasia with adenomatous transformation.
    Zimmerman D, Young WF, Ebersold MJ, Scheithauer BW, Kovacs K, Horvath E, Whitaker MD, Eberhardt NL, Downs TR, Frohman LA.
    J Clin Endocrinol Metab; 1993 Jan 01; 76(1):216-22. PubMed ID: 8421089
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Effects of hypophysiotropic factors on growth hormone and prolactin secretion from somatotroph adenomas in culture.
    Ishibashi M, Yamaji T.
    J Clin Endocrinol Metab; 1985 May 01; 60(5):985-93. PubMed ID: 2858494
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Monoclonal antibodies reveal circulating growth hormone of high molecular weight not detectable by conventional assays.
    Luthman M, Jónsdóttir I, Skoog B, Wivall IL, Roos P, Werner S.
    Acta Endocrinol (Copenh); 1990 Sep 01; 123(3):317-25. PubMed ID: 2239080
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. [The value of functional tests in diagnosis of prolactinoma].
    Klockenbusch W, Distler W, von Ditfurth M, Graf M, Jahn K.
    Geburtshilfe Frauenheilkd; 1990 May 01; 50(5):383-7. PubMed ID: 2115483
    [Abstract] [Full Text] [Related]

  • 38. Women with prolactin-producing pituitary adenoma show decreased serum placental lactogen during pregnancy.
    Luthman M, Bremme K, Eneroth P, Werner S.
    Gynecol Obstet Invest; 1993 May 01; 35(2):80-5. PubMed ID: 8449449
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Results of somatostatin receptor scintigraphy do not predict pituitary tumor volume- and hormone-response to ocreotide therapy and do not correlate with tumor histology.
    Plöckinger U, Bäder M, Hopfenmüller W, Saeger W, Quabbe HJ.
    Eur J Endocrinol; 1997 Apr 01; 136(4):369-76. PubMed ID: 9150695
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.